AIDS vaccine trial exceeds expectations

September 23, 2005

An experimental AIDS vaccine of Merck & Co. has exceeded expectations and led to a double enrollment in the trial to 3,000, researchers said.

The trial, conducted in healthy volunteers to determine their immune response to the vaccine, might indicate whether the immune reactions could prevent or control AIDS, reported the Wall Street Journal Friday.

The vaccine, called MRKAd5, uses an adenovirus -- a common-cold virus -- as a missile armed with man-made copies of three AIDS virus genes, has resulted in a stronger-than-expected immune response.

MRKAd5 has boosted such killer T-cells, which seek and destroy human cells infected by HIV by 50-fold to 100-fold -- an immune reaction comparable with successful vaccines for diseases like smallpox or measles, according to Lawrence Corey, principal investigator of the HIV Vaccine Trials Network in Seattle.

However, the vaccine doesn't elicit antibodies, another key element of immune protection.

Copyright 2005 by United Press International

Explore further: Experimental vaccine protects against multiple malaria strains

Related Stories

URMC drug extends effectiveness of HIV therapy

January 30, 2017

A drug developed at the University of Rochester Medical Center extends the effectiveness of multiple HIV therapies by unleashing a cell's own protective machinery on the virus. The finding, published today in the Journal ...

Recommended for you

Canada conservationist warns of 'cyber poaching'

February 25, 2017

Photographers, poachers and eco-tour operators are in the crosshairs of a Canadian conservationist who warns that tracking tags are being hacked and misused to harass and hunt endangered animals.

Polymer additive could revolutionize plastics recycling

February 24, 2017

When Geoffrey Coates, the Tisch University Professor of Chemistry and Chemical Biology, gives a talk about plastics and recycling, he usually opens with this question: What percentage of the 78 million tons of plastic used ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.